Sign In
NewsRadar

SuppreMol

SuppreMol develops novel therapeutics for the treatment of autoimmune diseases. The company is pioneering the development of soluble Fc gamma receptors (sFcgRs), which are recombinant autologous therapeutic proteins with a strong immunosuppressive potential. It plans to develop sFcgRs for the treatment of idiopathic thrombocytopenic purpura (ITP), systemic lupus erythematosus, rheumatoid arthritis and other autoimmune conditions. It is a spin-off from the Max Planck Institute for Biochemistry.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Am Klopferspitz 19
Martinsried / Munich 82152
Germany
+49-89-309050 68-0
+49-89-309050 68-68
http://www.suppremol.com
Peter Buckel
+49-89-309050 68-0

Company Facts
Founded:Dec 2002
Founders:Uwe Jacob, Robert Huber, Peter Sondermann
CEO:Peter Buckel
CTO or technical lead:Uwe Jacob
CFO or finance director:Michael Kring
Head of Sales:
Head of Marketing:

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,130
Tech investments
From our Online Data Service
16,883
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 13N/AEnergy related
Sep 13€12.6MConsumer electronics
Sep 12€39.0MBiopharmaceuticals
Sep 12N/AKnowledge management
Sep 12€2.3MInternet commerce
Sep 12€2.1MInternet services
Sep 12€4.0MMedical devices

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.